Analysis of factors influencing sleep disorders and the distribution characteristics of traditional Chinese medicine syndromes in people with early⁃or mid⁃stage Parkinson’s disease
|更新时间:2023-03-21
|
Analysis of factors influencing sleep disorders and the distribution characteristics of traditional Chinese medicine syndromes in people with early⁃or mid⁃stage Parkinson’s disease
Shanghai Journal of Traditional Chinese MedicineVol. 57, Issue 3, Pages: 21-25(2023)
LI Hui,YUAN Xiaolei,YE Qing,et al.Analysis of factors influencing sleep disorders and the distribution characteristics of traditional Chinese medicine syndromes in people with early⁃or mid⁃stage Parkinson’s disease[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(3):21-25.
LI Hui,YUAN Xiaolei,YE Qing,et al.Analysis of factors influencing sleep disorders and the distribution characteristics of traditional Chinese medicine syndromes in people with early⁃or mid⁃stage Parkinson’s disease[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(3):21-25. DOI: 10.16305/j.1007-1334.2023.2208083.
Analysis of factors influencing sleep disorders and the distribution characteristics of traditional Chinese medicine syndromes in people with early⁃or mid⁃stage Parkinson’s disease
Objective,2,To investigate the factors influencing sleep disorders and the distribution characteristics of traditional Chinese medicine (TCM) syndromes in patients with early- or mid-stage Parkinson’s disease (PD).,Methods,2,Based on the Parkinson’s Disease Sleep Scale (PDSS) score, 87 patients with early- or mid-stage PD were divided into the PD sleep disorder group (,n,=46) and the PD without sleep disorder group (,n,=41). Baseline data such as gender, age, age of onset, duration of illness, Hoeln-Yahr Stage, and scores of the Unified Parkinson Disease Rating Scale (UPDRS), Scales for Outcomes in Parkinson’s disease - Autonomic (SCOPA-AUT), Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Minimum Mental State Examination (MMSE) and the Parkinson’s Disease Questionnaire (PDQ-39) were analyzed and compared between the two groups. All patients with early- or mid-stage PD had TCM syndrome differentiation, the distribution pattern of TCM syndromes were analyzed, and the sleep condition in patients with different TCM syndromes were compared. Linear regression analysis or Logistic regression analysis was used to test for linear trends between the total PDSS score and each variable, and to explore the influencing factors of sleep disorders in early- or mid-stage PD patients.,Results,2,①No statistically significant baseline difference was found between the two groups (,P,>,0.05). The scores of SCOPA-AUT, HAMA, HAMD, PDQ-39 and subscales of UPDRS (I mentation, behavior and mood, Ⅱ activities of daily living, Ⅲ motor exam) were higher in the PD with sleep disorder group than those in the PD without sleep disorder group (,P,<,0.05). ②Among the 87 patients with early- or mid-stage PD collected in this study, there were 22 cases with qi and blood deficiency syndrome, 21 cases with qi stagnation and blood stasis syndrome, 15 cases with stirring wind due to phlegm-heat syndrome, and 29 cases with liver and kidney deficiency syndrome. There was a statistically significant difference in the distribution of TCM syndromes between the PD with sleep disorder group and the PD without sleep disorder group (,P,<,0.05). The most common TCM syndrome in the PD with sleep disorder group was liver and kidney deficiency syndrome (43.50%) while that in the PD without sleep disorder group was qi stagnation and blood stasis syndrome (41.50%). ③The differences in the total PDSS scores of early- or mid-stage PD patients with different TCM syndrome were statistically significant (,P,<,0.05), and the total PDSS score in patients with the liver and kidney deficiency syndrome was the lowest. ④The total PDSS score was negatively correlated with age, UPDRS Ⅰ, UPDRS Ⅱ, UPDRS Ⅲ, SCOPA-AUT, HAMA, HAMD and PDQ-39 scores (,r,<,0, ,P,<,0.05), and UPDRS Ⅰ, UPDRS Ⅱ, SCOPA-AUT, HAMA, HAMD, and PDQ-39 were risk factors (,P,<,0.05).,Conclusions,2,Older patients with early- or mid-stage PD are more likely to have sleep disorders, more severe motor and autonomic symptoms, as well as anxiety and depression, affecting their quality of life. The most common TCM syndrome of early- or mid-stage PD patients with sleep disorders is liver and kidney deficiency syndrome, and patients with this syndrome have the most serious sleep disorder.
关键词
帕金森病睡眠障碍中医证型肝肾不足证焦虑抑郁
Keywords
Parkinson’s diseasesleep disorderstraditional Chinese medicine syndromeliver and kidney deficiency syndromeanxietydepression
references
ALBERS J A, CHAND P, ANCH A M. Multifactorial sleep disturbance in Parkinson’s disease[J]. Sleep Med, 2017, 35: 41-48.
VAN UEM J M T, MARINUS J, CANNING C, et al. Health-Related Quality of Life in patients with Parkinson’s disease—A systematic review based on the ICF model[J]. Neurosci Biobehav Rev, 2016, 61: 26-34.
HAWKES C H, DEL TREDICI K, BRAAK H. A timeline for Parkinson’s disease[J]. Parkinsonism Relat Disord, 2010, 16(2): 79-84.
CHAUDHURI K R, PAL S, DIMARCO A, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease[J]. J Neurol Neurosurg Psychiatry, 2002, 73(6): 629-635.
GOETZ C G, TILLEY B C, SHAFTMAN S R, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results[J]. Mov Disord, 2008, 23(15): 2129-2170.
VISSER M, VAN ROODEN S M, VERBAAN D, et al. A comprehensive model of health-related quality of life in Parkinson’s disease[J]. J Neurol, 2008, 255(10): 1580-1587.
CAROD-ARTAL F J, MARTINEZ-MARTIN P, VARGAS A P. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version[J]. Mov Disord, 2007, 22(1): 91-98.
TOMLINSON C L, STOWE R, PATEL S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson’s disease[J]. Mov Disord, 2010, 25(15): 2649-2653.
SEPPI K, RAY CHAUDHURI K, COELHO M, et al. Update on treatments for nonmotor symptoms of Parkinson’s disease-an evidence-based medicine review[J]. Mov Disord, 2019, 34(2): 180-198.
HATANO T, HATTORI N, KAWANABE T, et al. An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson’s disease[J]. J Neural Transm Vienna Austria, 2014, 121(3): 275-281.
RANA A Q, QURESHI A R M, SHAMLI OGHLI Y, et al. Decreased sleep quality in Parkinson’s patients is associated with higher anxiety and depression prevalence and severity, and correlates with pain intensity and quality[J]. Neurol Res, 2018, 40(8): 696-701.
KAY D B, TANNER J J, BOWERS D. Sleep disturbances and depression severity in patients with Parkinson’s disease[J]. Brain Behav, 2018, 8(6): e00967.
Observation on regulating effect of spirit⁃regulating acupuncture on female overactive bladder and accompanying emotional abnormality
Discussion on “the heart governing mental activities” and traditional Chinese medicine treatment of psychocardiological diseases
Clinical observation on Ganjiang Xiaochaihu Decoction in treating patients with mild infection of COVID⁃19 Omicron variant
Research progress of traditional Chinese medicine treatment of depression in Parkinson’s disease
Clinical study on effect of modified Wuhu Zhuifeng Powder on non-motor symptoms of Parkinson’s disease patients with kidney deficiency and blood stasis syndrome
Related Author
No data
Related Institution
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Longhua Hospital,Shanghai University of Traditional Chinese Medicine
Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Department of Neurology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine